Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ATCOR MEDICAL HOLDINGS LIMITED
ABN 81 113 252 234
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | DONAL O'DWYER |
Date of last notice | 18 November 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | 6,067,517 fully paid ordinary shares 650,000 options over ordinary shares |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Dundrum Investments Pty Ltd as trustee for The O'Dwyer Family Trust. Mr Donal O'Dwyer & Mrs Judith O'Dwyer (Dundrum Super Fund A/c). |
Date of change | 23 December 2016 |
No. of securities held prior to change | 4,529,055 fully paid ordinary shares 650,000 options over ordinary shares |
Class | Fully paid ordinary shares |
Number acquired | 1,538,462 |
Number disposed | Nil |
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation | $100,000.03 |
No. of securities held after change | 6,067,517 fully paid ordinary shares 650,000 options over ordinary shares |
Nature of change Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back | Share purchase as approved by shareholders on 21 December 2016 |
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/a |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation | |
Interest after change |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | N/a |
If so, was prior written clearance provided to allow the trade to proceed during this period? | |
If prior written clearance was provided, on what date was this provided? |
Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ATCOR MEDICAL HOLDINGS LIMITED
ABN 81 113 252 234
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | DAVID BROOKES |
Date of last notice | 18 NOVEMBER 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct - 174,082 fully paid ordinary shares - 450,000 options over ordinary shares Indirect - 1,295,182 fully paid ordinary shares |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | DR D.L Brookes & Mrs E Brookes |
Date of change | 23 December 2016 |
No. of securities held prior to change | 1,161,572 fully paid ordinary shares 450,000 options over ordinary shares |
Class | Fully paid ordinary shares |
Number acquired | 307,692 |
Number disposed | Nil |
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation | $19,999.98 |
No. of securities held after change | 1,469,264 fully paid ordinary shares 450,000 options over ordinary shares |
Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back
Share purchase as approved by shareholders on 21 December 2016
Part 2 - Change of director's interests in contractsNote: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/a |
Nature of interest | |
Name of registered holder (if issued securities) | |
Date of change | |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | |
Interest acquired | |
Interest disposed | |
Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation | |
Interest after change |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | N/a |
If so, was prior written clearance provided to allow the trade to proceed during this period? | |
If prior written clearance was provided, on what date was this provided? |
AtCor Medical Holdings Limited published this content on 23 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 19 January 2017 07:46:07 UTC.
Original documenthttp://atcormedical.com/wp-content/uploads/2017/01/ACG0397.pdf
Public permalinkhttp://www.publicnow.com/view/DEC491426452FB30F1D3195EC3E9D1AF12EEB8B6